2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis

被引:17
|
作者
Brenol, Claiton Viegas
Henrique da Mota, Licia Maria
Cruz, Boris Afonso
Pileggi, Gecilmara Salviato
Pereira, Ivanio Alves
Rezende, Lucila Stange
Bertolo, Manoel Barros
Carioca Freitas, Max Victor
da Silva, Nilzio Antonio
Louzada-Junior, Paulo
Neubarth Giorgi, Rina Dalva
Correa Lima, Rodrigo Aires
Castelar Pinheiro, Geraldo da Rocha
机构
关键词
rheumatoid arthritis; vaccination; immunization; adult; JUVENILE IDIOPATHIC ARTHRITIS; YELLOW-FEVER VACCINATION; HERPES-ZOSTER; ANTI-TNF; INFLUENZA-VACCINATION; UNITED-STATES; SAFETY; THERAPY; RISK; INFECTION;
D O I
10.1016/S2255-5021(13)70002-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To elaborate recommendations to the vaccination of patients with rheumatoid arthritis (RA) in Brazil. Method: Literature review and opinion of expert members of the Brazilian Society of Rheumatology Committee of Rheumatoid Arthritis and of an invited pediatric rheumatologist. Results and conclusions: The following 12 recommendations were established: 1) Before starting disease-modifying anti-rheumatic drugs, the vaccine card should be reviewed and updated; 2) Vaccines against seasonal influenza and against H1N1 are indicated annually for patients with RA; 3) The pneumococcal vaccine should be indicated for all patients with RA; 4) The vaccine against varicella should be indicated for patients with RA and a negative or dubious history for that disease; 5) The HPV vaccine should be considered for adolescent and young females with RA; 6) The meningococcal vaccine is indicated for patients with RA only in the presence of asplenia or complement deficiency; 7) Asplenic adults with RA should be immunized against Haemophilus influenzae type B; 8) An additional BCG vaccine is not indicated for patients diagnosed with RA; 9) Hepatitis B vaccine is indicated for patients with RA who are negative for antibodies against HBsAg; the combined hepatitis A and B vaccine should be considered; 10) Patients with RA and at high risk for tetanus, who received rituximab in the preceding 24 weeks, should undergo passive immunization with tetanus immunoglobulin in case of exposure; 11) The YF vaccine is contraindicated to patients with RA on immunosuppressive drugs; 12) The above described recommendations should be reviewed over the course of RA.
引用
收藏
页码:4 / 23
页数:20
相关论文
共 50 条
  • [41] SCOTTISH SOCIETY OF RHEUMATOLOGY OCCUPATIONAL THERAPY RHEUMATOID ARTHRITIS WORK AUDIT
    Harkess, Janet E.
    McAlarey, Katie
    RHEUMATOLOGY, 2013, 52 : 38 - 38
  • [42] Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    De Cock, Diederik
    Watson, Kath D.
    Lunt, Mark
    Buch, Maya H.
    Isaacs, John D.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (10) : 1405 - 1412
  • [43] Delay in referral of rheumatoid arthritis patients to rheumatology clinic
    Saad, Sahar Ahmed
    Alhaj, Najwa Khalil
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2020, 47 (01)
  • [44] Delay in referral of rheumatoid arthritis patients to rheumatology clinic
    Sahar Ahmed Saad
    Najwa Khalil Alhaj
    Egyptian Rheumatology and Rehabilitation, 47
  • [45] The Risk Of Serious Infections In Patients Receiving Rituximab For Rheumatoid Arthritis: Results From The British Society For Rheumatology Biologics Register-Rheumatoid Arthritis
    Silva-Fernandez, Lucia
    Lunt, Mark
    Low, Audrey S.
    Watson, Kath D.
    Symmons, Deborah P.
    Hyrich, Kimme L.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S341 - S341
  • [46] Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Rutherford, Andrew I.
    Subesinghe, Sujith
    Hyrich, Kimme L.
    Galloway, James B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) : 905 - 910
  • [47] Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis
    Fernandez Sueiro, Jose Luis
    Juanola Roura, Xavier
    Canete Crespillo, Juan de Dios
    Torre Alonso, Juan Carlos
    Garcia de Vicuna, Rosario
    Queiro Silva, Ruben
    Ariza Ariza, Rafael
    Batlle Gualda, Enrique
    Loza Santamaria, Estibaliz
    REUMATOLOGIA CLINICA, 2011, 7 (03): : 179 - 188
  • [48] Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
    Balsa, Alejandro
    Fontecha, Petra Diaz del Campo
    Fernandez, Lucia Silva
    Martin, Jose Valencia
    Martinez, Virginia Nistal
    Vazquez, Fernando Leon
    Hernandez, M. Vanesa Hernandez
    Corominas, Hector
    Caliz, Rafael Caliz
    Garcia, Jose Maria Aguado
    Rodriguez, Gloria Candelas
    Roteta, Nora Ibargoyen
    Carvajal, Arturo Marti
    Farras, M. Nieves Plana
    Rioboo, Janet Punal
    Park, Hye Sang
    Pego, Yolanda Trinanes
    Garcia, Virginia Villaverde
    REUMATOLOGIA CLINICA, 2023, 19 (10): : 533 - 548
  • [49] Tolerance and Efficacy of Rituximab in Elderly Patients with Rheumatoid Arthritis Enrolled in the French Society of Rheumatology Air Registry
    Payet, Sarah
    Gottenberg, Jacques-Eric
    Mariette, Xavier
    Ravaud, Philippe
    Perrodeau, Elodie
    Bardin, Thomas
    Cacoub, Patrice P., Sr.
    Cantagrel, Alain G.
    Combe, Bernard
    Dougados, Maxime
    Flipo, Rene-Marc
    Godeau, Bertrand
    Guillevin, Loic
    Le Loet, Xavier X.
    Hachulla, Eric
    Schaeverbeke, Thierry
    Sibilia, Jean
    Pane, Isabelle
    Baron, Gabriel
    Soubrier, Martin
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S917 - S917
  • [50] Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register
    Soliman, Moetaza M.
    Hyrich, Kimme L.
    Lunt, Mark
    Watson, Kath D.
    Symmons, Deborah P. M.
    Ashcroft, Darren M.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (02) : 240 - 246